Acerus Reports Fourth Quarter and Full Year 2020 Financial Results
TORONTO, March 11, 2021 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX: ASP; OTCQB: ASPCF) today reported...
Day: March 11, 2021
Protara Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Business Overview
- Initiation of Phase 1 Trial of TARA-002 in Patients with Non-Muscle Invasive Bladder Cancer on Track to Commence by...
The Balancing Act® on Lifetime to Feature ENPP1 Deficiency
Educational Episode to Highlight Symptoms of ENPP1 Deficiency and the Importance of Early DiagnosisBOSTON, March 11, 2021 (GLOBE NEWSWIRE) -- Inozyme...
Humacyte to Present at Oppenheimer 31st Annual Healthcare Conference
DURHAM, N.C., March 11, 2021 (GLOBE NEWSWIRE) -- Humacyte, Inc., a clinical-stage biotechnology platform company developing universally implantable bioengineered human...
BioXcel Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
New Drug Application (“NDA”) submitted to the U.S. Food and Drug Administration (“FDA”) for BXCL501 for the acute treatment of schizophrenia...
Therma Bright Submits Application to Research Ethics Board for Approval of Clinical Trials for AcuVid(TM) COVID-19 Rapid Saliva-Based Antigen Test
Toronto, Ontario--(Newsfile Corp. - March 11, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), a progressive medical...
Allscripts rated #1 in Black Book™ Research’s 2021 Community Health Systems Vendors Report
Annual survey results reveal company receives top ranking in community setting for the fifth consecutive year CHICAGO--(BUSINESS WIRE)--$MDRX #HealthIT--Allscripts (NASDAQ:...
UroLift® System, a proven treatment for Benign Prostatic Hyperplasia (BPH), now reimbursed in France
A surgical option which is minimally invasive and available as same-day outpatient procedure1,2,3 WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX)– Men...